• OPEN AN ACCOUNT
Indian Indices
Nifty
25,082.30 -67.55
(-0.27%)
Sensex
82,253.46 -247.01
( -0.30%)
Bank Nifty
56,765.35 10.65
( 0.02%)
Nifty IT
37,273.70 -419.55
( -1.11%)
Global Indices
Nasdaq
44,384.39 -287.26
(-0.64%)
Dow Jones
6,279.98 -21.48
(-0.34%)
Hang Seng
39,468.95 -100.73
(-0.25%)
Nikkei 225
8,941.12 -34.54
(-0.38%)
Forex
USD-INR
85.68 -0.05
(-0.06%)
EUR-INR
100.36 -0.05
(-0.05%)
GBP-INR
116.41 -0.07
(-0.06%)
JPY-INR
0.59 0.00
(0.19%)

EQUITY - MARKET SCREENER

Nath Bio-Genes (India) Ltd
Industry :  Miscellaneous
BSE Code
ISIN Demat
Book Value()
537291
INE448G01010
341.3302463
NSE Symbol
P/E(TTM)
Mar.Cap( Cr.)
NATHBIOGEN
10.31
428.92
EPS(TTM)
Face Value()
Div & Yield %
21.89
10
0.89
 

Transformers & Rectifiers appoints Mukul Srivastava as CEO
Jul 08,2025

Mukul Srivastava is a seasoned professional with over 3 decades of rich experience in Executive Leadership, P&L management, and driving growth across multi-products. He has worked extensively in the Electrical Industry, particularly in the Transformers and Switchgear segments.

Mukul Srivastava expertise spans across Power and Distribution Transformers, Instrument Transformers, Condenser Bushings, Vacuum Circuit Breakers, Ring Main Units, Unitized Sub Stations, Gas Insulated Switchgears, and Numerical Relays. He joins us from CG Power & Industrial Solutions.

Gujarat-based Transformers & Rectifiers (India) is engaged in manufacturing of transformers and reactors in India. It erves a wide range of sectors, including power generation, transmission and distribution, railways, renewable energy, infrastructure, industrial manufacturing, etc.

The company's consolidated net profit surged 125% to Rs 94.17 crore on a 32% increase in revenue from operations to Rs 676.48 crore in Q4 March 2025 over Q4 March 2024.

Shares of Transformers and Rectifiers shed 0.86% to Rs 484.45 on the BSE.